Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

S Schimrigk; N Brune; K Hellwig; C Lukas; B Bellenberg; M Rieks; V Hoffmann; D Pöhlau; H Przuntek

doi:10.1111/j.1468-1331.2006.01292.x

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

Identifier:nobleid.org/w1/20260515/AF32BE73

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF32BE73.svg?ark=w1%2F20260515%2FAF32BE73)](https://nobleid.org/work/w1/20260515/AF32BE73)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.

Identifier:nobleid.org/w1/20260515/AF32BE73

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF32BE73.svg?ark=w1%2F20260515%2FAF32BE73)](https://nobleid.org/work/w1/20260515/AF32BE73)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work